- Home
- FITB vs GEHC Comparison
FITB vs GEHC Comparison
Compare FITB & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FITB
- GEHC
- Stock Information
- Founded
- FITB 1858
- GEHC 1892
- Country
- FITB United States
- GEHC United States
- Employees
- FITB N/A
- GEHC N/A
- Industry
- FITB Major Banks
- GEHC Computer Software: Prepackaged Software
- Sector
- FITB Finance
- GEHC Technology
- Exchange
- FITB Nasdaq
- GEHC Nasdaq
- Market Cap
- FITB 29.9B
- GEHC 33.1B
- IPO Year
- FITB N/A
- GEHC N/A
- Fundamental
- Price
- FITB $42.03
- GEHC $77.65
- Analyst Decision
- FITB Buy
- GEHC Buy
- Analyst Count
- FITB 16
- GEHC 9
- Target Price
- FITB $49.94
- GEHC $84.89
- AVG Volume (30 Days)
- FITB 10.6M
- GEHC 2.9M
- Earning Date
- FITB 10-17-2025
- GEHC 10-29-2025
- Dividend Yield
- FITB 3.79%
- GEHC 0.18%
- EPS Growth
- FITB 11.33
- GEHC 41.40
- EPS
- FITB 3.35
- GEHC 4.88
- Revenue
- FITB $8,125,000,000.00
- GEHC $19,967,000,000.00
- Revenue This Year
- FITB $15.69
- GEHC $6.02
- Revenue Next Year
- FITB $21.94
- GEHC $4.59
- P/E Ratio
- FITB $12.62
- GEHC $16.27
- Revenue Growth
- FITB 0.77
- GEHC 2.31
- 52 Week Low
- FITB $32.25
- GEHC $57.65
- 52 Week High
- FITB $49.07
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- FITB 44.35
- GEHC 58.46
- Support Level
- FITB $41.58
- GEHC $72.67
- Resistance Level
- FITB $43.03
- GEHC $79.75
- Average True Range (ATR)
- FITB 1.14
- GEHC 1.90
- MACD
- FITB 0.02
- GEHC 0.49
- Stochastic Oscillator
- FITB 48.83
- GEHC 78.34
About FITB Fifth Third Bancorp
Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).